جست‌وجوی استاد و پژوهشگر

Amy K Johnsonمشاهده پروفایل

دانشیار

• Adolescent Sexual and Reproductive Health
• Sexually Transmitted Diseases
• HIV Prevention
• +۳ مورد دیگر

Amy K Johnson, PhD, serves as Associate Professor in Pediatrics (Adolescent and Young Adult Medicine) at Northwestern University's Feinberg School of Medicine, with clinical affiliation at Ann & Robert H. Lurie Children's Hospital of Chicago. She holds key roles in the Institute for Public Health and Medicine (IPHAM) - Center for Dissemination and Implementation Science, Northwestern University Clinical and Translational Sciences Institute (NUCATS), and Robert J. Havey, MD Institute for Global Health (IGH). Dr. Johnson earned her PhD from the University of Illinois, Chicago in 2016. Her research centers on adolescent sexual and reproductive health with dual emphases on HIV/STI intervention implementation and ethical dimensions of community participation in cure research. She develops prevention packages targeting adolescents—particularly young women—and addresses surveillance gaps in sexually transmitted diseases through implementation science frameworks. Analysis of her 2024-2025 publications reveals a dominant focus on PrEP implementation across diverse populations and geographies. Her work consistently addresses health disparities through mixed-methods approaches, examining structural barriers among Black women in Chicago, migrant communities in France, and youth in Nigeria. Common threads include innovative delivery strategies (text messaging, peer navigation), cultural adaptation of interventions, and ethical considerations in community engagement—demonstrating her commitment to translating research into equitable prevention solutions. Her scientific contributions have been recognized with the Excellence in Scholarship award from Lurie Children's Hospital (2023) and Best Poster Award from the American Sexually Transmitted Disease Association (2016). Excellence in Scholarship, Lurie Children's Hospital (2023) Best Poster Award, American Sexually Transmitted Disease Association (2016) Dr. Johnson actively shapes public health practice through leadership in the Illinois PrEP Working Group, Getting to Zero Illinois, and as Vice Chair of Epidemiology for the Illinois Public Health Association. Her editorial role at Frontiers in Reproductive Health and memberships in the American College of Epidemiology and American Public Health Association reflect her influence in advancing methodological rigor and equity-focused HIV prevention science. Current projects like iCARE Nigeria and POWER Up demonstrate her commitment to scalable interventions addressing the HIV care continuum.

• Causal inference
• Machine learning
• Cluster randomized trials
• +۷ مورد دیگر

Laura Balzer, PhD, MPhil is an Associate Professor of Biostatistics at the University of California, Berkeley . Her research focuses on methodological and applied work in causal inference , machine learning , and messy real-world data , particularly in the context of HIV prevention and global health in East Africa. PhD – Biostatistics, University of California, Berkeley (2015) MPhil – Computational Biology, University of Cambridge (2009) BS – Applied Mathematics, University of Vermont (2008) Dr. Balzer specializes in the design and analysis of cluster randomized and pragmatic trials , addressing challenges like differential measurement , complex dependence , and missing data . Her work integrates epidemiologic methods with machine learning to enhance rigor in real-world studies. Recent publications emphasize community-based HIV interventions , dynamic choice models , and causal inference frameworks for global health applications in Kenya and Uganda. Her methodological contributions include Two-Stage TMLE for handling sub-sampling and non-independent units , while applied studies examine HIV-tuberculosis interactions , hypertension care models , and social network effects on health outcomes. Dr. Balzer’s role as a Primary Statistician for East African studies underscores her commitment to translating academic advances into public health impact .

• Radiation Oncology
• Brachytherapy
• Hodgkin Disease
• +۷ مورد دیگر

Kenneth B. Roberts, MD , is a Professor of Therapeutic Radiology at Yale School of Medicine and a practicing academic physician specializing in pediatric cancers, lymphomas, leukemias, sarcomas, and colo-anal cancers. He serves as Chief of the Cardiac Brachytherapy, Lymphoma/Sarcoma Radiotherapy, and Pediatrics Radiotherapy Programs at Yale and is Associate Chief of Radiation Oncology at Yale-New Haven Hospital. Education : BS in Chemistry and Biology from Massachusetts Institute of Technology (1979) MD from Duke University (1984) Residency in Radiation Oncology at Duke University Medical Center (1992), Internal Medicine at Ohio State University Hospitals (1987) Fellowship in Hematology-Oncology at Duke (1989) MS in Legal Studies from Duke University School of Law (1994) Research Interests center on brachytherapy , combined modality therapy , and the long-term effects of radiation therapy (e.g., secondary malignancies). He investigates dose optimization in Hodgkin’s disease, radiation economics, and late toxicity in pediatric patients. Recent Publications focus on pediatric Hodgkin lymphoma , prognostic scoring in lymphomas, brachytherapy applications , and late cardiac toxicity in survivors. His work also addresses economic drivers in radiotherapy adoption and subsequent cancer risks . Scientific Awards Elected Fellow of ASTRO (2024) America’s Top Doctors in New York Metro Area (since 2005) America’s Top Doctors for Cancer (since 2006) 1998 Travel Award to European Society of Therapeutic Radiology and Oncology Clinical Trials include sub-investigator roles in studies on pediatric gliomas , stereotactic body radiotherapy for lung cancer, Inotuzumab Ozogamicin for leukemia, and germ cell tumors .

Ajaz Sheikhمشاهده پروفایل

دانشیار

• Sleep Medicine
• Intraoperative Monitoring
• Epilepsy
• +۳ مورد دیگر

Ajaz Sheikh, M.D. serves as Associate Professor and Director of the Clinical Neurophysiology Fellowship Program at the University of Toledo College of Medicine, specializing in Epilepsy, Sleep Medicine, and Intraoperative Monitoring. His clinical work integrates advanced neurophysiological diagnostics with comprehensive patient care at the Neuroscience Center. Education: M.B.B.S: University of Kashmir, Government Medical College Srinagar (1998-2004) Internship: University of Toledo (2010-2011) Residency: Psychiatry (University of Kashmir, 2005-2008); Neurology (University of Toledo, 2011-2014) Fellowship: Clinical Neurophysiology/Epilepsy (Case Medical Center, 2014-2015); Sleep Medicine (Duke University, 2015-2016) Dr. Sheikh's research examines seizure triggers, comorbidities in drug-resistant epilepsy, and neurophysiological diagnostic challenges. His work bridges clinical practice with systematic reviews on rare neurological conditions like CLIPPERS and Isaac Syndrome, emphasizing practical applications for improving diagnostic accuracy and treatment protocols in neurocritical care settings. Recent publications (2023-2025) reveal a strong focus on epilepsy comorbidities, with significant contributions to understanding ADHD-epilepsy interactions, geriatric seizure patterns, and autoimmune neurological disorders. His systematic reviews on CLIPPERS and Isaac Syndrome demonstrate methodological rigor while addressing critical gaps in rare disease management. Scientific Awards: Alpha Omega Alpha Induction (2023) A.B. Baker Teaching Recognition Award (2020) Outstanding Neurology Attending Award (2018-2019) Arnold P. Gold Humanism Award (2013, 2014) Outstanding Resident Teaching Award (2014) As Principal Investigator for the ENGAGE-E-001 alprazolam trial and Co-Investigator on four active epilepsy drug studies (natalizumab, padsevonil, XEN1101, SAGE-547), Dr. Sheikh leads translational research targeting super-refractory status epilepticus and drug-resistant focal epilepsy. His prior work in Kashmir included schizophrenia and depression drug trials, reflecting global research engagement. Through the Clinical Neurophysiology Fellowship Program, Dr. Sheikh trains next-generation neurophysiologists while collaborating on multi-center trials that advance evidence-based protocols for complex seizure disorders and intraoperative monitoring standards.

Alejandro Benjamin Balazsمشاهده پروفایل

استادیار

• Immunology
• Virology
• Molecular Biology
• +۹ مورد دیگر

Alejandro Benjamin Balazs is an Assistant Professor of Medicine at the Ragon Institute of MGH, MIT, and Harvard. His laboratory specializes in synthetic immunology, gene transfer technologies, and immune system engineering to combat HIV and emerging viral threats like SARS-CoV-2. Current research focuses include: Understanding sterilizing immunity mechanisms against HIV. Studying pathogen escape from immunological pressure. Optimizing AAV vector delivery for broadly neutralizing antibodies. Investigating innate immune responses in viral neutralization. His lab has published extensively on: Antibody-mediated prophylaxis against HIV and SARS-CoV-2. Viral evolution and immune escape dynamics. AAV-based gene delivery systems. Humoral immunity in vulnerable populations. Immune signatures in humanized mouse models. Scientific accolades include: NIDA Avenir New Innovator (DP2) Grant (2015) Gilead Sciences Research Scholars Award (2016) MGH Transformative Research Scholars Award (2016) Doctoral students mentored in his lab include: Jackie Brady (Harvard BBS Program, 2015-2020) Allen Lin (Harvard Systems Biology, 2015-2020) Meredith Phelps (Harvard Virology, 2018-2022)

Judith Litvin Danielsمشاهده پروفایل

دانشیار

• Cellular and Molecular Developmental Biology
• Cardiac Development
• Bone Biology
• +۲ مورد دیگر

Judith Litvin Daniels is an Associate Professor at Temple University's Lewis Katz School of Medicine, specializing in Biomedical Education and Data Science. She chairs the Curriculum Committee, serves as Vice Chair of Education, and acts as Ombudsperson and Educator across Medical, Dental, Podiatry, and Graduate levels. PhD in Nutrition-Biochemistry, University of North Carolina Post-doctoral Fellowships at Cornell University Medical School and University of Virginia Her research spans cellular and molecular developmental biology, focusing on avian heart development, cardiac progenitor cells, and the role of Periostin-Like-Factor (PLF) in bone-heart connections. Recent work explores PLF's role in bone formation and disease. Key article trends include cardiac development , bone biology , extracellular matrix proteins , and inflammatory responses . Collaborative studies address clinical applications in traumatic brain injury and cancer biology. She has mentored students at all academic levels, with many winning regional/national awards, and organized faculty mentorship workshops. Publications highlight collaborations in Cell Molecular Life Sciences , J Cell Biochemistry , and Development . Labs and teams at Temple University focus on integrating molecular biology with translational research, particularly in the Fels Cancer Institute for Personalized Medicine.

Marla Kellerمشاهده پروفایل

استاد

• HIV Prevention in Women
• Vaginal Microbicides
• Pre-Exposure Prophylaxis (PrEP)
• +۴ مورد دیگر

Dr. Marla Keller is a tenured Professor of Medicine and Obstetrics & Gynecology at Albert Einstein College of Medicine, currently serving as Executive Dean and holder of the Jacob and Jeanne Barkey Chair in Medicine. Director, NIH-funded Harold and Muriel Block Institute for Clinical and Translational Research Interim Senior Associate Dean for Clinical and Translational Research Vice Chair of Research for Department of Medicine Dr. Keller's research focuses on: Biomedical HIV prevention strategies Vaginal microbicide development PrEP implementation in women Cervical cancer screening in HIV+ women Immune responses to SARS-CoV-2 COVID-19 clinical trials Her recent publications emphasize: HPV infection and cervical precancer Vaginal microbiome interactions PrEP delivery systems HIV/HSV coinfection dynamics Convalescent plasma therapy Metronidazole treatment response Key scientific awards include: Infectious Disease Mentoring Award (2013) COVID-19 Distinguished Service Award (2021) Spirit of Achievement Changemaker Award (2023) New York Super Doctor (2011-2015)

Kamila A. Alexanderمشاهده پروفایل

دانشیار

• Health Equity
• Intimate Partner Violence
• HIV/AIDS Prevention
• +۵ مورد دیگر

Kamila A. Alexander, PhD, RN, is an Associate Professor and Director of the PhD, DNP/PhD, and Postdoctoral Programs at the Johns Hopkins School of Nursing. She holds the endowed Natalie and Wes Bush Rising Professorship. Her research integrates health equity and social justice frameworks to examine socio-structural determinants of trauma, violence, and sexual/reproductive health outcomes among marginalized youth, with emphasis on intimate partner violence, HIV resilience, and economic opportunity. Education Dr. Alexander earned: B.S. in Exercise Science (Howard University) BSN and MSN/MPH (Johns Hopkins School of Nursing) PhD in Nursing Science (University of Pennsylvania) Research Focus Her work spans: Socio-structural drivers of health disparities Intersections of violence, trauma, and sexual/reproductive health Community-engaged interventions to promote HIV resilience Policy impacts on health equity for Black and Latino communities Publication Trends Recent articles (2019–2024) cluster around reproductive coercion, intimate partner violence, and HIV/STI prevention, employing mixed-methods approaches. Key themes include gender-based power dynamics, structural barriers in healthcare, and culturally responsive intervention strategies. Awards & Honors Notable recognitions: Betty Irene Moore Fellowship for Nurse Leaders (2020) Dean’s Award for Outstanding Nurse Researcher (2020) Johns Hopkins Catalyst Award (2018) New Nurse Faculty Fellowship (2015) Leadership & Affiliations She directs NIH-funded training programs and chairs key initiatives including: Nursing Initiative, Mid-Atlantic CFAR Consortium Violence Working Group, Johns Hopkins Center for Injury Research NIH T32 Training Program in Trauma and Violence She is affiliated with six Hopkins research centers focused on global health equity, adolescent health, and infectious diseases.

• Infection Prevention
• Antimicrobial Resistance
• Epidemiology
• +۳ مورد دیگر

Dr. Kerri Thom serves as Professor in the Department of Epidemiology and Public Health and Department of Medicine at the University of Maryland School of Medicine, holding the administrative role of Associate Dean for Student Affairs while directing the Office of Student Research and advising medical students through the Office of Student Affairs. Education: M.D. from University of Florida College of Medicine Internal Medicine Residency and Infectious Disease Fellowship at University of Maryland Medical Center and Baltimore VA Medical Center M.S. in Epidemiology and Clinical Research from University of Maryland School of Medicine Her research concentrates on infection prevention, antimicrobial resistance mechanisms, and transmission dynamics of multidrug-resistant pathogens—especially Acinetobacter baumannii —in healthcare environments. She develops evidence-based interventions for antimicrobial stewardship and infection control, addressing critical gaps in reducing healthcare-associated infections through clinical epidemiology and translational research. Analysis of Dr. Thom's publication record reveals sustained focus on healthcare epidemiology, with methodological diversity spanning clinical trials, observational studies, and mathematical modeling. Her work evaluates interventions across varied clinical contexts—from trauma resuscitation to transplant surgery—emphasizing practical strategies to combat multidrug-resistant organism transmission and antibiotic resistance. Dr. Thom actively mentors medical students through curriculum development and research supervision via the Office of Student Research. She has secured significant competitive funding from NIH, CDC, and AHRQ for projects targeting antibiotic resistance transmission and infection prevention. Selected Grants: CDC: "Transmission of Antibiotic Resistant Bacteria from Patient-to-Patient in Healthcare Setting and the Impact of Contact Precautions" (PI, 9/2018-9/2019) CDC: "Epicenters for the Prevention of Healthcare Associated Infections" (Co-Investigator, 9/2018-9/2020) AHRQ: "Removing barriers to hand hygiene and glove compliance: evaluation of two novel, time-efficient interventions" (PI, 8/2015-5/2019) CDC: "Epicenters for the Prevention of Healthcare Associated Infections (HAI) Cycle II" (Investigator, 9/2015-9/2018) ARLG: "ESBL-producing Enterobacteriaceae in solid organ transplant recipients" (Investigator, 7/2016-7/2018) CDC: "Impact of Post-antibiotic Prescription Review on Antibiotic Use and Resistance" (Co-PI, 9/2013-12/2016) NIH K23: "Epidemiology of Acinetobacter baumannii: An Emerging Nosocomial Pathogen" (9/2010-12/2016) As a key contributor to the CDC Epicenters program, Dr. Thom collaborates with national researchers on healthcare-associated infection prevention while leading student research initiatives that cultivate future clinician-scientists in infectious disease epidemiology.

Rahima Benhabbourمشاهده پروفایل

دانشیار

• Drug Delivery Systems
• Biomedical Engineering
• Polymer Chemistry
• +۷ مورد دیگر

Rahima Benhabbour is an Associate Professor in the Lampe Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill, with an adjunct appointment at the UNC Eshelman School of Pharmacy . Her work bridges polymer chemistry, engineering, and pharmacology to create innovative drug delivery platforms. Ph.D. in Chemistry (McMaster University, 2008) MSc in Medicinal Chemistry (University of Minnesota, 2001) Research focuses on polymer-based biomedical devices for HIV prevention and cancer treatment , emphasizing translational science and 3D-printed intravaginal rings . Articles highlight trends in biomaterials , multipurpose prevention , and nano-delivery systems . KL-2 CTSA Award (2015-2018) for HIV prophylaxis research Teaches BMME 890 - Special Topics and BMME 900 - Research in Biomedical Engineering . Lab is affiliated with the Center in Nanotechnology and Drug Delivery and collaborates with clinical experts in HIV/oncology.

• Neurosurgery
• Neuro-Oncology
• Meningioma Management
• +۴ مورد دیگر

Professor Michael D. Jenkinson holds the Sir John Fisher / RCS England Chair of Surgical Trials at the University of Liverpool , where he is also Professor of Neurosurgery. His work focuses on meningioma management, brain metastases, and interventional clinical trials, with funding from MRC, Brain Tumour Charity, and NIHR. PhD in Neuroscience (Imaging and Biology of Oligodendroglial Tumours) Consultant Neurosurgeon at The Walton Centre (2010–present) Chief Investigator on NIHR-funded trials: ROAM, STOP 'EM, SPRING, ReStart Research Interests: Meningioma growth modeling and personalized monitoring Seizure prophylaxis in neurosurgery Surgical trials methodology Quality of life assessments in neuro-oncology Leadership Roles: Chair, SBNS Academic Committee Chair, EORTC Meningioma Committee Member, NIHR HTA Prioritisation Committee Co-Investigator on PROSSPER and FUTURE GB trials

Ram Bajpaiمشاهده پروفایل

مدرس

• Epidemiology
• Biostatistics
• Survival Analysis
• +۷ مورد دیگر

Dr. Ram Bajpai is a Lecturer in Epidemiology/Applied Statistics at Keele University's School of Medicine. He joined in 2019 as part of the Research Institute for Primary Care and Health Sciences, combining active research and teaching roles. Previously, he worked at the Lee Kong Chian School of Medicine (Nanyang Technological University, Singapore) and the Army College of Medical Sciences (India). Education: BSc in Statistics/Mathematics (University of Lucknow), MSc Health Statistics (Banaras Hindu University), PhD in Medical Statistics (Guru Gobind Singh Indraprastha University). Research focuses on cross-domain applications of statistical/epidemiological methods, including survival analysis, Bayesian methods, risk prediction modelling, and evidence synthesis. Teaching experience includes biostatistics modules for medical students at multiple institutions. Current research interests span prognostic studies, meta-analysis, complex data analysis, and design of epidemiological studies. Key contributions include systematic reviews on gout prophylaxis safety, dementia prognostic factors, and long-term outcomes of pediatric COVID-19. Active in collaborative projects on aging populations, musculoskeletal health, and public health interventions.

• HIV/AIDS
• Infectious Diseases
• Public Health
• +۳ مورد دیگر

Quarraisha Abdool Karim, PhD, is a Professor of Epidemiology at Columbia University's Mailman School of Public Health and holds a joint appointment in Public Health at the Nelson R Mandela School of Medicine, University of KwaZulu-Natal. She is the Associate Scientific Director of CAPRISA and a visiting scientist at Massachusetts General Hospital and Visiting Lecturer at Harvard University. Her research focuses on HIV/AIDS epidemiology, particularly in South African adolescent populations, and includes landmark studies like the CAPRISA 004 tenofovir gel trial (2010), recognized as a Top 10 scientific breakthrough by Science . Education: BS, University of Durban-Westville (1981) MS, Columbia University (1988) Research Interests: Reducing HIV transmission in young women Antiretroviral therapy implementation in resource-limited settings Global health capacity building through programs like the Columbia University Southern African Fogarty AITRP Awards: John Dirks-Canada Gairdner Award in Global Health L’Oréal-UNESCO Women in Science Laureate for Africa and the Middle East Order of Mapungubwe (Bronze) Leadership Roles: Chair, South African National AIDS Council Prevention Technical Task Team Member, UNAIDS Scientific Expert Panel Vice-President, African Academy of Sciences Key Projects: CAPRISA 007 RHIVA trial addressing HIV prevention in rural KwaZulu-Natal WHO Solidarity Trial evaluating antiviral drugs for COVID-19

• Pediatric Ophthalmology
• Strabismus
• Amblyopia
• +۷ مورد دیگر

Jill Rotruck, MD, is an Assistant Professor of Ophthalmology and Visual Science at Yale School of Medicine, where she serves as a Fellowship-trained pediatric ophthalmologist and adult strabismus specialist at the Yale Eye Center. Her clinical practice encompasses comprehensive pediatric ophthalmology, strabismus in children and adults, amblyopia, nasolacrimal duct obstruction, pediatric cataracts, eyelid disease, and various other pediatric ophthalmic conditions. BS in Biology and BA in Music from Shepherd University MD from West Virginia University School of Medicine Internship in Internal Medicine at West Virginia University Ophthalmology Residency at California Pacific Medical Center Pediatric Ophthalmology and Strabismus Fellowship at Duke Eye Center Dr. Rotruck's research program focuses on advancing pediatric vision care through innovative approaches including binocular treatments for amblyopia, application of optical coherence tomography in pediatric eye disease, and pediatric ocular infection management. She is particularly interested in developing telehealth solutions for pediatric ophthalmology, having contributed to research evaluating vision screening devices during the pandemic to enhance patient convenience while maintaining quality care. Her work on improving amblyopia treatment outcomes has been influential in shaping AAPOS guidelines. Dr. Rotruck serves on the American Association of Pediatric Ophthalmology and Strabismus Vision Screening Committee and contributes to EyeWiki as an editorial board member. She is actively involved in resident education and international medical outreach initiatives. American Academy of Ophthalmology Fellow (2018) Alpha Omega Alpha (AOA) Honor Medical Society Membership (2011) John E. Prescott Award for Academic Excellence (2009) Joseph McMurran Scholar (2006) Phi Kappa Phi National Honor Fraternity Member (2006) Through her clinical work, research, and teaching, Dr. Rotruck is dedicated to improving pediatric vision outcomes and quality of life for children with eye conditions. She emphasizes the importance of early vision development, noting that 'Helping to ensure that children are set up to develop the best vision they can has repercussions that impact so many aspects of their daily experience throughout their lifetime.'

Bouke de Jongمشاهده پروفایل

استاد

• Mycobacteriology
• Molecular Epidemiology
• Tuberculosis Research
• +۸ مورد دیگر

Bouke de Jong is a Professor and Unit Head of Mycobacteriology at the Institute of Tropical Medicine in Antwerp, Belgium. She holds a PhD and MD in Medicine, alongside an MSc in Epidemiology from the Netherlands Institute for Health Sciences and the University of Amsterdam. Her research focuses on molecular epidemiology of Mycobacterium species, including tuberculosis (TB), Buruli Ulcer, and leprosy, emphasizing improved diagnostics, treatment optimization, and evaluating public health interventions to curb transmission. Supported by an ERC Starting Grant, she leads a team studying the impact of interventions on disease spread in endemic regions. Education and Academic Qualifications: PhD in Medicine, University of Amsterdam MD in Medicine MSc in Epidemiology, Netherlands Institute for Health Sciences Research Interests: Improved molecular diagnostics for TB, Buruli Ulcer, and leprosy Phylogeography and phylodynamics of Mycobacterium species Optimized treatment regimens for drug-resistant strains Public health strategies to reduce transmission Grant and Project Activity: Dr. de Jong oversees 82 active projects, including ERC-funded research on drug-resistant TB lineages and USAID-supported Tuberculosis Implementation Framework Agreements (TIFA DRC). Notable collaborations involve studies in The Gambia, Rwanda, Niger, the Comoros, and Cuba, addressing TB epidemiology, drug resistance, and clinical intervention efficacy. Scientific Contributions: Her work has advanced understanding of M. africanum, transmission dynamics of M. leprae, and the development of rapid diagnostic methods like ethanol-based RNA preservation and tongue swab culturing. She advocates for global health security funding and participates in clinical trials optimizing treatments for multidrug-resistant infections.